Clinical Trials Directory

Trials / Sponsors / Veloxis Pharmaceuticals

Veloxis Pharmaceuticals

Industry · 18 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingVEL-101 to Prevent Rejection After Kidney Transplantation
Transplantation, Kidney
Phase 22026-07-01
CompletedA Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-10
Healthy Volunteers
Phase 12022-04-26
TerminatedAssess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients
Chemotherapy-induced Peripheral Neuropathy
Phase 12022-03-24
WithdrawnA Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-ba
Chemotherapy-induced Peripheral Neuropathy
Phase 22021-10-01
CompletedPharmacokinetic Comparison Of All FK-506 Formulations
Renal Failure
Phase 32015-01-01
CompletedCrossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
Renal Failure
Phase 32013-11-01
CompletedMulticenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney T
Renal Failure
Phase 22012-11-01
CompletedSwitching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Renal Failure, Tremors
Phase 32011-12-01
CompletedDouble-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
Renal Failure
Phase 32010-09-01
CompletedSafety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice
Renal Failure
Phase 32008-12-01
CompletedPharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients
Liver Failure
Phase 22008-10-01
CompletedPharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patie
Kidney Failure, Renal Failure
Phase 22008-09-01
TerminatedLCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Autoimmune Hepatitis
Phase 22007-12-01
CompletedPharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
Liver Failure
Phase 22007-11-01
Completed12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
Dyslipidemia
Phase 2 / Phase 32007-10-01
CompletedStudy of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
Dyslipidemia
Phase 22007-07-01
CompletedPharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
Renal Failure
Phase 22007-07-01
Approved For MarketingExpanded Access Study for Renal Transplant Patients With Envarsus XR ™
Renal Failure
——